EXOSEAL vascular Closure Device
FDA premarket approval P100013/S020 · decided 2019-06-21
Approval details
- PMA number
- P100013
- Supplement
- S020
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- EXOSEAL vascular Closure Device
- Generic name
- Device, hemostasis, vascular
- Applicant
- Cordis US Corporation
- Date received
- 2019-05-24
- Decision date
- 2019-06-21
- Days to decision
- 28 days
- Decision code
- OK30
- Product code
- MGB
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Miami Lakes, FL
- Statement
- Transfer of Final Release activities from the Cordis Miami Lakes site to the Cordis de Mexico site.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.